An observational study of type 2 diabetes within a large Australian tertiary hospital pediatric diabetes service

Sandra D Ruhayel1, Rebecca A James, Sarah Ehtisham

  • 1Department of Endocrinology and Diabetes at the Royal Children's Hospital, Parkville, Victoria, Australia.

Pediatric Diabetes
|March 27, 2010
PubMed

Insights

Type 2 diabetes mellitus (T2DM) in youth is a growing concern. This study found that young T2DM patients have significant comorbidities like dyslipidemia and hypertension, posing challenges for management.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Public Health

Background:

  • Type 2 diabetes mellitus (T2DM) is increasingly prevalent in children and adolescents.
  • This demographic shift presents unique clinical challenges.
  • Understanding the characteristics of pediatric T2DM is crucial for effective healthcare strategies.

Purpose of the Study:

  • To identify pediatric patients diagnosed with T2DM within a large tertiary hospital's diabetes service.
  • To investigate the clinical course and management aspects of T2DM in this young population.
  • To assess the burden of T2DM on specialized diabetes services.

Main Methods:

  • An initial 6-year audit of the diabetes service was conducted.
  • A subsequent 2-year prospective case ascertainment period identified T2DM patients.
  • Comprehensive data collection was performed on identified individuals.

Main Results:

  • 33 pediatric patients with T2DM were identified out of 1574 total patients.
  • High rates of comorbidities were observed: dyslipidemia (56%), microalbuminuria (45%), hypertension (30%), and retinopathy (25%).
  • Hypertension correlated with higher BMI, while retinopathy was associated with elevated HbA1c levels. 27% were lost to follow-up.

Conclusions:

  • Pediatric T2DM currently represents a low burden on the studied diabetes service.
  • Patients diagnosed with T2DM in youth experience significant health complications.
  • Developing effective management strategies for pediatric T2DM is a major challenge.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.